Subscribe to Search results

In Philip Cuthbert's written statement, he stated that his father's death certificate not referring to AIDS, HIV, Hepatitis C "or even haemophilia" amounted to them "trying to cover up the truth" even on his death certificate.

Published on:

Benjamin Griffiths made an application to the EIBSS and received conflicting advice as he was unable to speak to the same EIBSS employee.

Published on:

Research was underway at PFC to find a way of physically removing Hepatitis B.

Published on:

Reported at symposium in Groningen that heat treatment at 68°C for 24 hours inactivated HIV; PFC was heating its Factor 8 stocks; CBLA announced plans to heat all BPL Factor 8 by April 1985.

Published on:

PFC issued Z8, the equivalent of 8Y free from hepatitis as well as HIV.

Published on:

The blood products unit moved to a new site in Liberton. It was named the Protein Fractionation Centre and was specifically designed for the fractionation of plasma.

Published on:

The facilities for the Protein Fractionation Centre were completed.

Published on:

In his written statement, Dr Foster said that a reduction in pool size around the early 1980s would have led to "an increase in importation of USA-donor derived Factor VIII concentrate which, in my opinion, carried a greater risk of HIV infection."

Published on:

Within his witness statement to the Inquiry, Dr Peter Foster advised it was known to be unlikely that PFC would begin production before the end of 1973. Construction began in 1971. It continued until 1974.

Published on:

Dr Peter Foster was shocked when Dr John Cash told him that the German company Behringwerke had announced at a symposium in Bonn that it was pasteurising Factor 8, as he had thought heat could not be used to inactivate virus in factor products.

Published on:

Dr John Cash established the SNBTS Coagulation Factor Study Group.

Published on:

In his written evidence to the Inquiry, Lord Norman Fowler noted that the overspend on the BPL project reflected "poorly on the Department".

Published on:

The delays and additional expenses incurred in the redevelopment of the BPL were caused by the complexity of the new plant site and build, the various re-designs which took place during the project, poor management from the CBLA, and a lack of close oversight by the DHSS.

Published on:

An incoming chief executive of the CBLA was reported to have told officials that on the basis of a lifetime's experience in the pharmaceutical industry the new BPL building represented value for money.

Published on:

Ministers invested money into the BPL project at a very considerable level despite the financial pressures on health spending at the time.

Published on:

In his written evidence to the Inquiry, Lord Norman Fowler recounted his own experience of the shortcomings in the Department of Health's system of handling private office papers, recording "it was quite evident that they didn't have a system [for storing papers]."

Published on:

Scotland tended to be the most independent when it came to healthcare, whereas Wales and Northern Ireland more closely followed the DHSS.

Published on:

On 14 November 1983 Kenneth Clarke MP told Parliament that "there is no conclusive evidence that acquired immune deficiency syndrome (AIDS) is transmitted by blood products" and that same statement asserted that professional advice had been made available to all haemophilia centres in relation to the possible risks of AIDS from Factor 8 concentrates. It was unclear what information or professional advice was provided to him in making this statement.

Published on:

David Watters said, with the benefit of hindsight, that the Haemophilia Society may not have pursued claims for compensation for hepatitis with the enthusiasm it should have done.

Published on:

When David Watters joined the Haemophilia Society there were only two other paid employees, part-time secretaries who worked only mornings.

Published on: